164 related articles for article (PubMed ID: 6036279)
1. Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy.
Shearer RV; Dubois EL
Am J Ophthalmol; 1967 Aug; 64(2):245-52. PubMed ID: 6036279
[No Abstract] [Full Text] [Related]
2. [Multimodal imaging of hydroxychloroquine and chloroquine retinopathy].
Sellam A; Massamba N; Le Hoang P; Bodaghi B
J Fr Ophtalmol; 2016 Jan; 39(1):111-3. PubMed ID: 26631575
[No Abstract] [Full Text] [Related]
3. Ocular toxicity of antimalarial drugs. Long-term follow-up.
Carr RE; Henkind P; Rothfield N; Siegel IM
Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592
[No Abstract] [Full Text] [Related]
4. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
[No Abstract] [Full Text] [Related]
5. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.
Laaksonen AL; Koskiahde V; Juva K
Scand J Rheumatol; 1974; 3(2):103-8. PubMed ID: 4608161
[No Abstract] [Full Text] [Related]
6. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
7. Electroretinography in patients with connective tissue diseases treated with hydroxychloroquine.
Sassaman FW; Cassidy JT; Alpern M; Maaseidvaag F
Am J Ophthalmol; 1970 Oct; 70(4):515-23. PubMed ID: 5505469
[No Abstract] [Full Text] [Related]
8. [Antimalarial's retinopaty remains a current threat].
Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
[No Abstract] [Full Text] [Related]
9. Corneal staining in systemic lupus erythematosus.
Spaeth GL
N Engl J Med; 1967 May; 276(21):1168-71. PubMed ID: 4164621
[No Abstract] [Full Text] [Related]
10. Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy.
Mazzuca SA; Yung R; Brandt KD; Yee RD; Katz BP
J Rheumatol; 1994 Jan; 21(1):59-63. PubMed ID: 8151589
[TBL] [Abstract][Full Text] [Related]
11. [Transitory retinopathy caused by prolonged treatment with hydroxychloroquine sulfate].
Chiari JJ; Freyberg RH
Arch Med Panamenos; 1965 Apr; 14(1):23-32. PubMed ID: 5839434
[No Abstract] [Full Text] [Related]
12. PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS.
TUFFANELLI D; ABRAHAM RK; DUBOIS EI
Arch Dermatol; 1963 Oct; 88():419-26. PubMed ID: 14051353
[No Abstract] [Full Text] [Related]
13. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
14. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
[TBL] [Abstract][Full Text] [Related]
15. A 6-step rapid desensitization protocol to hydroxychloroquine.
Sutton KM; Fernando SL
Ann Allergy Asthma Immunol; 2021 Mar; 126(3):292-293. PubMed ID: 33276119
[No Abstract] [Full Text] [Related]
16. [Experiences with long-term immunosuppressive therapy of connnective tissue diseases].
Apostoloff E; Reitzig P; Jendrusch C; Apostoloff G
Z Gesamte Inn Med; 1974 Jan; 29(1):26-30. PubMed ID: 4820047
[No Abstract] [Full Text] [Related]
17. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy.
Bernstein HN
Am J Med; 1983 Jul; 75(1A):25-34. PubMed ID: 6869408
[TBL] [Abstract][Full Text] [Related]
18. [The visual system in 30 subjects with discoid lupus erythematosus treated with hydroxychloroquine].
Rossi A; Rinaldi M; Vozza A; Romano A; Turco P
G Ital Dermatol Venereol; 1988 Apr; 123(4):189-92. PubMed ID: 3182010
[No Abstract] [Full Text] [Related]
19. [THE VALUE OF HYDROXYCHLOROQUINE (PLAQUENIL) THERAPY IN CHRONIC DISCOID LUPUS ERYTHEMATOSUS].
KRAAK JH; VAN KETEL W; PRAKKEN JR; VAN ZWET W
Ned Tijdschr Geneeskd; 1965 Mar; 109():461-9. PubMed ID: 14339782
[No Abstract] [Full Text] [Related]
20. Maculopathy in patient with systemic lupus erythematosus treated with hydroxychloroquine.
Rodríguez-Hurtado FJ; Sáez-Moreno JA; Rodríguez-Ferrer JM
Reumatol Clin; 2012; 8(5):280-3. PubMed ID: 22481059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
